Total Payments
$279,997
2024 Payments
$2,028
Companies
80
Transactions
1,238
Medicare Patients
6,608
Medicare Billing
$624,151
Payment Breakdown by Category
Other$173,708 (62.0%)
Travel$36,860 (13.2%)
Gifts$28,875 (10.3%)
Food & Beverage$21,876 (7.8%)
Consulting$18,598 (6.6%)
Education$80.01 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $168,700 | 69 | 60.3% |
| Travel and Lodging | $36,860 | 95 | 13.2% |
| Gift | $28,875 | 3 | 10.3% |
| Food and Beverage | $21,876 | 1,056 | 7.8% |
| Consulting Fee | $18,598 | 9 | 6.6% |
| Honoraria | $5,008 | 2 | 1.8% |
| Education | $80.01 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $227,213 | 280 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $17,945 | 2 | $0 (2019) |
| Allergan, Inc. | $15,183 | 62 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $5,222 | 83 | $0 (2024) |
| Medtronic MiniMed, Inc. | $2,105 | 29 | $0 (2020) |
| ABBVIE INC. | $1,515 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,038 | 79 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $827.99 | 46 | $0 (2024) |
| Amgen Inc. | $812.14 | 46 | $0 (2024) |
| PFIZER INC. | $692.83 | 95 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 110 | ABBVIE INC. ($303.30) |
| 2023 | $64,786 | 180 | Corcept Therapeutics ($62,903) |
| 2022 | $61,058 | 182 | Corcept Therapeutics ($58,845) |
| 2021 | $88,133 | 230 | Corcept Therapeutics ($85,965) |
| 2020 | $21,057 | 145 | Corcept Therapeutics ($19,276) |
| 2019 | $30,652 | 131 | Zimmer Biomet Holdings, Inc. ($17,945) |
| 2018 | $5,305 | 123 | AstraZeneca Pharmaceuticals LP ($3,847) |
| 2017 | $6,979 | 137 | Allergan Inc. ($3,619) |
All Payment Transactions
1,238 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/23/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Diagnostics | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 10/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/14/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Cranial Orthotic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,287 | 4,174 | $533,267 | $229,623 |
| 2022 | 15 | 1,191 | 2,079 | $350,972 | $145,041 |
| 2021 | 15 | 1,287 | 2,162 | $394,961 | $167,971 |
| 2020 | 10 | 843 | 1,283 | $225,517 | $81,515 |
Total Patients
6,608
Total Services
9,698
Medicare Billing
$624,151
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 441 | 1,036 | $232,064 | $91,856 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 363 | 363 | $86,394 | $47,201 | 54.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 283 | 284 | $49,984 | $22,560 | 45.1% |
| G0513 | Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | Office | 2023 | 326 | 326 | $44,010 | $20,580 | 46.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 353 | 353 | $19,062 | $9,096 | 47.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 359 | 359 | $13,642 | $6,741 | 49.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 356 | 356 | $13,528 | $6,685 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $20,618 | $5,956 | 28.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 387 | 474 | $17,064 | $5,103 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $8,525 | $3,592 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $6,321 | $2,559 | 40.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 104 | 104 | $7,696 | $2,241 | 29.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 69 | 69 | $3,726 | $1,759 | 47.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 33 | 36 | $4,896 | $1,718 | 35.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 21 | $3,225 | $937.62 | 29.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 27 | 152 | $1,976 | $841.39 | 42.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $266.00 | $133.28 | 50.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 90 | $270.00 | $65.39 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 387 | 1,041 | $233,184 | $92,307 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 233 | 233 | $55,454 | $30,941 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $21,970 | $6,309 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 63 | $9,765 | $3,208 | 32.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 110 | 110 | $4,180 | $2,119 | 50.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $4,104 | $2,033 | 49.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 34 | 41 | $6,321 | $1,986 | 31.4% |
About Dr. Matthew Young, MD
Dr. Matthew Young, MD is a Family Medicine healthcare provider based in Colorado Springs, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821060062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Young, MD has received a total of $279,997 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 1,238 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($168,700).
As a Medicare-enrolled provider, Young has provided services to 6,608 Medicare beneficiaries, totaling 9,698 services with total Medicare billing of $624,151. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Colorado Springs, CO
- Active Since 02/02/2006
- Last Updated 05/23/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821060062
Products in Payments
- Korlym (Drug) $227,213
- Zimmer Biomet Instruments and Implants (Device) $17,945
- BOTOX (Biological) $14,166
- FASENRA (Drug) $3,737
- Minimed 670G System (Device) $2,079
- UBRELVY (Drug) $932.06
- VRAYLAR (Drug) $636.09
- GLASSIA (Biological) $611.73
- Otezla (Drug) $485.83
- Ozempic (Drug) $470.67
- NURTEC ODT (Drug) $437.43
- FARXIGA (Drug) $436.98
- Aimovig (Biological) $359.27
- EMGALITY (Drug) $323.77
- REXULTI (Drug) $313.26
- BOTOX CHRONIC MIGRAINE (Drug) $306.85
- QULIPTA (Drug) $256.64
- TRULICITY (Drug) $216.41
- BEVESPI AEROSPHERE (Drug) $205.10
- BREZTRI (Drug) $201.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Colorado Springs
Dr. Lawrence Andrews, M.d, M.D
Family Medicine — Payments: $69,688
Family Medicine $69,688
Elizabeth Erickson, M.d, M.D
Family Medicine — Payments: $31,801
Family Medicine $31,801
Dr. Daniel Rohweder, D.o, D.O
Family Medicine — Payments: $25,097
Family Medicine $25,097
Ripley Hollister, M.d, M.D
Family Medicine — Payments: $12,095
Family Medicine $12,095
Dr. Paul Cump, D. O, D. O
Family Medicine — Payments: $9,579
Family Medicine $9,579
Dr. Mark Fraley, D.o, D.O
Family Medicine — Payments: $9,425
Family Medicine $9,425